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Background: While alternating current stimulation (ACS) is gaining relevance as a tool
in research and approaching clinical applications, its mechanisms of action remain
unclear. A review by Schutter and colleagues argues for a retinal origin of transcranial
ACS’ neuromodulatory effects. Interestingly, there is an alternative application form of
ACS specifically targeting α-oscillations in the visual cortex via periorbital electrodes
(retinofugal alternating current stimulation, rACS). To further compare these two
methods and investigate retinal effects of ACS, we first aim to establish the safety and
tolerability of rACS.
Objective: The goal of our research was to evaluate the safety of rACS via finite-element
modeling, theoretical safety limits and subjective report.
Methods: 20 healthy subjects were stimulated with rACS as well as photic stimulation
and reported adverse events following stimulation. We analyzed stimulation parameters
at electrode level as well as distributed metric estimates from an ultra-high spatial
resolution magnetic resonance imaging (MRI)-derived finite element human head model
and compared them to existing safety limits.
Results: Topographical modeling revealed the highest current densities in the anterior
visual pathway, particularly retina and optic nerve. Stimulation parameters and finite
element modeling estimates of rACS were found to be well below existing safety limits.
No serious adverse events occurred.
Conclusion: Our findings are in line with existing safety guidelines for retinal and neural
damage and establish the tolerability and feasibility of rACS. In comparison to tACS,
retinofugal stimulation of the visual cortex provides an anatomically circumscribed model
to systematically study the mechanisms of action of ACS.
Keywords: retinofugal alternating current stimulation, electrical stimulation, feasibility, tolerability, safety,
adverse events, finite element modeling
Abbreviations: EF, electrical field; NiBS: non-invasive brain stimulation; NRS, numeric rating scale; PS, photic stimulation;
rACS: retinofugal alternating current stimulation; RPE, retinal pigment epithelium; tACS, transcranial alternating
current stimulation.
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INTRODUCTION
Non-invasive brain stimulation (NiBS) is an effective method for
research, as well as a promising tool for therapy in cognitive
and clinical neuroscience (Paulus, 2003; Hallett, 2007; Liew
et al., 2014). Its effects range from direct brief modification
of neural activity to long lasting recovery maximization
following neural injury (Hallett, 2005; Talelli and Rothwell,
2006; Hummel et al., 2008; Sandrini and Cohen, 2013).
Recently, transcranial alternating current stimulation (tACS),
characterized by oscillatory low-voltage stimulation, showed
promising effects on the motor system (Feurra et al., 2011, 2013),
motor performance (Pogosyan et al., 2009; Joundi et al., 2012),
memory (Marshall et al., 2006; Polania et al., 2012), higher
order cognition (Santarnecchi et al., 2013, 2016) and tremor
(Brittain et al., 2013). Despite these encouraging results, tACS’
mechanisms of action remain unclear (Zaghi et al., 2010) and a
retinal contribution to its effects on neural synchrony is still being
discussed (Schutter, 2016).
Retinofugal alternating current stimulation (rACS) is a
comparably novel form of alternating current stimulation (ACS).
In contrast to tACS, rACS is characterized by transmission along
retinofugal tracts terminating predominantly in cortical visual
areas and neuromodulation of central rhythms (Gall et al., 2011;
Schmidt et al., 2013a). While differing from other forms of NiBS
in regard to stimulation site, rACS shares its use of alternating
current and effects on the intrinsic frequencies of the visual
system with tACS (Schmidt et al., 2013a; Haberbosch et al.,
2019). Moreover, in comparison to other forms of NiBS (namely,
most types of tES) with diffusely induced electric fields (EF)
throughout large parts of the brain (Peterchev et al., 2012), rACS
affects the well-defined retinofugal pathway (Rager and Singer,
1998) for stimulation confined to the visual system. Thus, rACS
renders a unique means to study mechanisms underlying NiBS as
it physiologically affects the circumscribed primary visual cortex
with separate input from each eye.
Before any novel method can be employed to its full potential
or compared with other methodologies, establishing its safety and
tolerability is critically important (Bath et al., 2014). The lack of
knowledge of safety parameters could culminate in ineffective
or even hazardous use (Antal et al., 2008; Bath et al., 2014).
While ineffective stimulation could lead to incoherent findings
regarding stimulation effects, effective but hazardous use could
possibly result in severe adverse events and lasting damages in
stimulation subjects. As rACS is used for research purposes, its
safety as well as tolerability has to be determined rigorously.
Refraining from potentially dangerous invasive measures,
the safety of a novel NiBS montage should be assessed in
several different ways.
Firstly, stimulation parameters can be compared to theoretical
safety limits as established for NiBS and neural tissue damage
in animal studies (Agnew and McCreery, 1987; Liebetanz et al.,
2009; Jackson et al., 2017), which have since been used to
assess NiBS safety in human studies (Poreisz et al., 2007; Bikson
et al., 2009, 2016). The primarily employed metrics include
current density (A/m2) and charge density (C/m2), although
other parameters such as charge per phase (C/ph) have been
proposed to account for the shifting polarity of AC stimulation
(Nitsche et al., 2003; Merrill et al., 2005).
Secondly, these safety metrics can be modeled onto CNS
structures (Datta et al., 2011; Bikson et al., 2016), to determine
the possibility of damage at critical locations (Bikson et al., 2016)
while accounting for anatomy and electrode position (Bikson
et al., 2009; Bikson and Datta, 2012; Peterchev et al., 2012;
Saturnino et al., 2015).
Finally, experimental validation of theoretical results by
subjective reports of adverse events with validated questionnaires
can be acquired (Brunoni et al., 2011). These reports are also
instrumental in assessing the tolerability of the novel method.
In this study we hypothesized that rACS is to be considered
safe if: (1) Stimulation parameters (current and charge densities
at the electrode) are within theoretical safety limits, (2) finite
element modeling data shows the same for EF estimates and
current densities at eye, retina and cortex, and (3) adverse events
do not exceed that of other established stimulation methods in
rate as well as severity.
To address the primary hypothesis, the stimulation parameters
of rACS were recorded during stimulation and employed for the
calculation of safety limits. Ultra-high resolution topographical
finite element modeling was performed to identify regions of
critical interest and to calculate theoretical safety parameters.
Adverse events were identified with an extended adverse events
questionnaire developed for tDCS (Brunoni et al., 2011). For
direct experimental comparison, we employed simple and safe
photic stimulation (PS) (Walker et al., 1944) as the gold-standard
method for stimulation of the retinofugal pathway regarding
safety and clinical experience (Cobb, 1947; Trenite et al., 1999).
MATERIALS AND METHODS
To address the safety profile of rACS, we observed and questioned
20 test subjects during rACS and PS sessions. We assessed
cutaneous, retinal and central adverse events and drew a
comparison between PS and rACS.
Participants
We stimulated 20 healthy volunteers (10 men), mean age
25.9 ± 4.95, as part of a study investigating a common
framework of action for NiBS. The subjects were interviewed
prior to experimentation regarding their state of health. We
applied established exclusion criteria for NiBS (Brunoni et al.,
2012) and added evidence for photophobia and photosensitive
epilepsy. Written informed consent was obtained from all
individual participants included in the study. The subjects
received financial compensation for their participation.
All procedures were performed in accordance with the
ethical standards of the Ethics Committee of the Charité –
Universitätsmedizin Berlin (“Ethikkommission der Charité –
Universitätsmedizin Berlin”) and with the 1964 Declaration
of Helsinki and its later amendments. This study adheres
to the principles of good scientific practice of the Charité –
Universitätsmedizin Berlin (“Grundsätze der Charité zur
Sicherung guter wissenschaftlicher Praxis”).
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Retinofugal Alternating Current
Stimulation (rACS)
Retinofugal alternating current stimulation was applied via
a multi-channel low-voltage stimulation device certified for
clinical use, which delivered weak oscillatory current sinus-
pulses over four individual periorbital electrodes, respectively
(NextWave, Eyetronic, Germany). The four superficial active
stimulating electrodes (Grass SAFELEADTM gold electrodes,
Astro-Med, Inc., RI, United States) were contained in foam-
padded stimulation goggles and bilaterally made skin contact via
small felt buffers (0.35 cm2) superior and inferior to the eye. The
return electrode (rectangular electrode, 30 × 30 mm polished
stainless steel) was fastened on the back of the neck at the midline.
Alternating current was applied at 10 Hz, as ACS has shown
robust effects at this frequency (Kanai et al., 2008; Helfrich et al.,
2014; Vossen et al., 2015) and gold standard PS typically also
employs 10 Hz stimulation (Photic driving) (Walker et al., 1944).
Stimulation amplitude was set to 120% phosphene threshold
(resulting in 351.69 µA (SD 63.95) peak-to-peak amplitude). The
phosphene threshold was determined employing an ascending
method of limits (Herrick, 1967) provided by the NextWave
software. rACS was delivered in 30 s blocks followed by 30 s
pauses over 10 min. The subjects were told to keep their eyes open
and focus a fixed point on a white surface in 1 m distance for the
duration of the experiment.
To assess the safety parameters of stimulation we additionally
calculated the effective amplitude. The effective amplitude of the
applied current is defined as the time normed integral of the
signal, which simplifies to its mean value for discrete signals as
is the case here, since the used stimulator receives an equidistant
sampled discrete function as input. In the simplest case of a pure
sine wave this simplifies to the following formula:
a(eff ) = amax√
2
In the case of more complex stimuli such as noise+ sine wave or
signals with an additional amplitude modulation, the use of peak-
to-peak “a(max)” values to describe the resulting electrical power
of an electric current stimulation would be misleading.
Regarding charge, we decided to refrain from more complex
line integral calculations, and instead used the following
simple formula:
Q = I ∗ t
This was done to ensure straightforward comparability of
resulting values. It also adds to the rigidity of our safety
considerations by rather over-than underestimating the
injected charge.
Photic Stimulation
Photic Stimulation was applied via two 3 × 5 cm multi-color
white LEDs contained in the stimulation goggles, which work
via red, green and blue LEDs mixing their emissions to form
white light. To be able to compare stimulation intensities with
rACS, sinusoidal pulses of white light were applied at an intensity
of 120% light threshold and with a frequency of 10 Hz. This
threshold was also determined by an ascending method of limits
and resulted in an average luminous intensity of 1.24 cd (±0.44)
for stimulation.
The stimulation was also delivered in 30 s blocks followed
by 30 s pauses over 10 min, and the subjects received the same
instructions as for rACS.
Modeling
The ultra-high resolution head and neck model (MIDA:
Multimodal Imaging-Based Detailed Anatomical Model)
available through the IT’IS Foundation was used in this
study (Iacono et al., 2015). The nifti (.nii) color masks
from the MIDA model were first processed in MATLAB
to re-create segmentation masks based on intensity values.
These masks were then imported into Simpleware (Synopsys
Ltd., CA, United States) and any errors in continuity and
anatomical details were manually corrected for Datta
et al. (2012). Masks with similar electrical conductivities
were then merged to a single compartment barring the
regions of interest (eye structures) in order to perform
individual current flow analysis through them. For instance,
mandible, teeth, vertebra, skull dipole, skull inner table,
skull outer table, hyoid bone were combined with the skull
mask but eye retina, choroid, and sclera were treated as
individual masks.
The stimulation electrodes were created as CAD files
mimicking the exact physical geometry and dimensions of
the electrodes used in the experiments. The electrodes were
positioned interactively within the image data simulating the
electrode montage used for rACS (see Figure 1C). The
adaptive meshes derived from the segmentation masks were
then imported into COMSOL Multiphysics (Burlington, MA,
United States) for finite element computation. The final
model comprised >10 million elements with >15 million
degrees of freedom.
The representative isotropic average electrical conductivities
assigned to the different tissue compartments and the electrode
materials (in S/m) are listed in Table 1.
The Laplace equation was solved and current densities
corresponding to 350 µA total current were applied at the
anode or active electrode (s). Ground was applied at the return
electrode and all other external surfaces were treated as insulated.
The linear iterative solver of conjugate gradients with a relative
tolerance of 1E-6 was used.
Surface as well as cross-sectional EF magnitude maps on the
gray matter, retina, and the optic nerve were obtained. For the
scalp, the surface current density magnitude plot was obtained.
Questionnaire
The questionnaire we employed is based on the one proposed
by Brunoni et al. (2011) and investigated the presence of
headaches, difficulties in concentrating, acute mood changes,
visual perceptual changes, fatigue and discomforting sensations
tingling, itching and/or burning under the electrodes during
and after rACS, as well as PS. The item “Difficulties in
concentrating” was defined in accordance with Montgomery and
Asberg (1979), while the item “Fatigue” was defined in accordance
with Chaudhuri and Behan (2004).
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FIGURE 1 | Model segmentation and finite element analysis. The ultra-high resolution MIDA model was adapted for analysis in this study. (A) Skin tissue mask with
periorbital electrodes (gray: electrode; blue: sponge). (B) The modeled brain, cranial nerves, blood vessels, eye structure, optic nerves, and electrodes (both active
periorbital and the return inion electrode shown). (C) Zoomed view corresponding to the dashed section in panel (B) highlighting segmentation detail in the region of
interest. Finite element analysis of current flow produced by rACS: Induced electric field magnitude plots on the cortical and eye level perspective (D) and bottom
view (E). A representative axial 2D cross-section view of electric field magnitude following the retinofugal tract was chosen and plotted (F). Panel (G) shows the
induced electric field on the eyes and optic nerve. Panel (H) shows the rear view. Panel (I) shows the primary visual cortex (V1) corresponding to the dashed section
in panel (H). A representative 2D axial cross-section view of electric field magnitude taken at the level of half of the visual cortex along the superior–inferior plane is
shown in panel (J).
We modified the questionnaire by adding a description
of phosphenes. Furthermore, to assess the overall tolerability,
we defined the broad category of “Pain” as a summary of all
discomforting sensations mentioned above and added a Numeric
Rating Scale (NRS-11, 11 stages from 0 to 10, 10 being the
strongest imaginable pain and 0 the absence of pain) (Farrar
et al., 2001) as a more in-depth and reliable measurement
(Downie et al., 1978). We discarded the four-point intensity
rating for the other categories to avoid a “halo effect” bias
(Streiner and Norman, 2008). We assumed that the foreign
body feeling reported for physiologically similar transcorneal
electrical stimulation (TCES) came from the electrode lying
directly on the cornea (Gekeler et al., 2006) and therefore decided
not to include it.
Three months after stimulation, the subjects received a second
questionnaire to identify late and longer lasting after-effects.
As the data is not normally distributed and equal variance
of residuals cannot be assumed, the severity of pain was
analyzed in Wilcoxon Signed Ranks Tests for paired samples.
The nominally scaled side effects were analyzed in Fishers
Exact Tests, as expected values in several of the cells of a
contingency table are below the recommended threshold for a
classical Chi-Squared Test (Larntz, 1978). P-values of<0.05 were
considered significant. All analyses were performed using IBM
SPSS Statistics, Version 19.0.0.1 (IBM, United States).
RESULTS
Stimulation Parameters
An average 10 Hz phosphene threshold at 290.50 µV (SD 45.36),
impedances at 12.05 k (SD 2.89), and an average amplitude
of 351.69 µA (SD 63.95) were noted. Calculated from peak-to-
peak amplitude, the current density at electrode level amounted
to a mean 1.00 mA/cm2 (SD 0.28), and the charge density to
0.60 C/cm2 (SD 0.11). As sine waves pulses were employed,
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TABLE 1 | Assigned electrical conductivities.
Tissue compartment/Electrode material Electrical conductivity (S/m)
Scalp 0.465
Muscle 0.35
Skull 0.01
CSF 1.65
Gray Matter 0.276
White Matter 0.126
Fat 0.04
Blood vessels 0.7
Eye Lens 0.32
Eye Retina/Choroid/Sclera 0.623
Eye Vitreous 1.55
Eye Cornea 0.5
Eye Aqueous 1.5
Optic Tract/Optic Chiasm/Cranial Nerve II 0.126
Air 1.00E−07
Sponge (felt buffer) 1.84
Periorbital electrode (gold electrodes) 4.10E+07
Inion electrode (stainless steel) 1.45E+06
The representative isotropic average electrical conductivities assigned to the
different tissue compartments and the electrode materials (in S/m).
we additionally calculated the effective amplitude, resulting in a
mean 248.68 µA (SD 47.0). Using effective amplitude, current
density amounted to a mean 0.71 mA/cm2 (SD 0.13), and
the charge density to 0.42 C/cm2 (SD 0.08). RACS was found
to be well within safety limits and the findings comparable
to other similar stimulation methods (see Table 2). Regarding
stimulation amplitude, rACS (0.35 mA) was comparable to
most TCES and tES montages (ranging from 0.08 to 1.2 mA).
Electrosleep and the maximum intensity stimulation employed
by Gekeler et al. (2006) were found to employ higher amplitudes
(3–25 mA). The stimulated area (0.35 cm2) is smaller than most
tES montages (16–35 cm2), comparable only to Electrosleep and
TCES (0.35–1.25 cm2). Regarding stimulation frequencies, rACS
was compared to studies using similar frequencies (10–20 Hz),
with the exceptions of Electrosleep, which is set at higher
frequencies (100 Hz) as well as the non-oscillating tDCS and
Gekeler’s TCES. The calculations following these observations
place the charge density of rACS just above the TCES of Ma et al.
(2014) and far below the safety limit published by Liebetanz et al.
(2009). This is consistent for charge per phase and charge density
per phase. Regarding current density, rACS (1 mA/cm2) ranks
below Ma (1.2 mA/cm2), well below the maximum intensity
employed by Gekeler (8.57 mA/cm2) and far below the safety
limit proposed by McCreery (25 mA/cm2). These findings are
even more pronounced when using effective amplitude.
Finite Element Modeling
The EF distributed by rACS is strongest at the eye level,
with the highest current density estimates at the retina.
Further areas of elevated current densities are optic nerve and
cortex (Figures 1A,B).
The calculated maximum current density at the retina
amounted to a maximum of 1.24 A/m2, while optic nerve
(0.33 A/m2) and cortex (0.13 A/m2) were both subjected to less
current flow. Regarding the EF, we estimated a maximum of
2.6 V/m in the optic nerve, followed by 1.99 V/m for the retina
and 0.47 V/m for the cortex. Finally, current density at skin
level underneath the active electrode amounted to a maximum
induced value of 14.79 A/m2 (Figure 1C), with the EF estimated
at 31.80 V/m. It should be noted that due to edge effects, the
observed values are higher than the current density toward the
middle of the electrode which is simply the current injected over
the contact area. For a detailed view, see Table 3.
TABLE 2 | Comparison of stimulation parameters.
Amplitude Area Duration Frequency Current density Charge density Charge per phase CD per phase
(mA) (cm2) (min) (Hz) (mA/cm2) (C/cm2) (C/ph) (C/(cm2∗ph))
Safety limits (Agnew and McCreery, 1987) – – – – 25 – – 0.000400
Safety limits (Liebetanz et al., 2009) 0.5 0.035 10 – 14.29 85.714 – –
(52.400)
rACS 0.35 0.35 10 10 1 0.599 0.000035 0.0001
rACS (effective amplitude) 0.25 0.35 10 10 0.71 0.423 0.000025 0.000071
Electrosleep (Sergeev, 1963) 25 1.25 60 100 20 72 0.00025 0.0002
TCES (Ma et al., 2014) 1.2 1 5 20 1.2 0.36 0.00006 0.00006
TCES (Delbeke et al., 2001) 0.28 1.25 7 10 0.22 0.094 0.000028 0.000022
TCES (Gekeler et al., 2006) max 3 0.35 7 – 8.57 – – –
TCES (Gekeler et al., 2006) optimal 0.08 0.35 7 – 0.22 – – –
tACS (Antal et al., 2008) 0.4 16 5 10 0.03 0.008 0.00004 0.000003
tSDCS (Paulus et al., 2013) 0.25 16 4 10 0.02 0.004 0.000025 0.000002
tDCS (Nitsche et al., 2003) 1 35 9 – 0.03 – – –
Current density measures at electrode level employed for stimulation types employing continuous current (TCES (Gekeler) and tDCS), charge density, charge per phase
and charge density (CD) per phase for oscillatory stimulation (rACS, Electrosleep, TCES (Ma and Delbeke), tACS and tSDCS).
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TABLE 3 | Modeling data and comparison to safety limits.
Current density Electric field
(mA/cm2) (V/m)
Safety limits Liebetanz et al., 2009 14.29 42
rACS (retina) Max 0.124 1.99
Mean 0.007 0.11
Median 0.005 0.08
rACS (optic nerve) Max 0.033 2.6
Mean 0.003 0.2
Median 0.002 0.14
rACS (cortex) Max 0.013 0.47
Mean 0.001 0.05
Median 0.001 0.04
rACS (V1) Max 0.003 0.12
Mean 0.001 0.03
Median 0.001 0.03
This table presents the finite element modeling results for rACS: Current density
and electric field estimates for retina, optic nerve, cortex and specifically the primary
visual cortex (V1) in comparison to reported safety limits.
TABLE 4 | Adverse events for rACS and PS.
Photic
rtACS Stim
n % n %
Pain (overall) During 8 40 4 20
After 0 0 2 10
Fatigue During 7 35 4 20
After 7 35 4 20
Tingling During 14 70 0 0
After 0 0 0 0
Headache During 0 0 3 15
After 1 5 1 5
Itching During 6 30 0 0
After 5 25 0 0
Burning During 6 30 0 0
After 0 0 0 0
Difficulties in Concentrating During 0 0 0 0
After 0 0 2 10
Metallic Taste During 3 15 0 0
After 0 0 0 0
Muscle twitches During 3 15 0 0
After 0 0 0 0
Acute mood changes During 0 0 0 0
After 0 0 0 0
Nausea During 0 0 0 0
After 0 0 0 0
Reports of adverse events during and after stimulation in subjects and percent (data
rounded to integers).
Adverse Events
Table 4 summarizes the adverse events in the 20 rACS and PS
sessions in healthy participants. None of the subjects requested
the stimulation to be terminated or required medical attention.
In their subjective reports, rACS associated adverse events were
predominant during stimulation, and PS associated adverse
events were predominant following stimulation. More explicitly,
a tingling sensation occurred in 70% of the subjects during but
not after rACS. An itching sensation under the electrodes was
reported by 30% of the subjects during rACS and 25% after
rACS. A burning sensation was felt by 30% of the participants
during but not after rACS. Fatigue occurred during, as well as
after, stimulation in 35 and 20% of the rACS and PS group,
respectively. Headaches were reported only by PS participants
during stimulation (15%). After stimulation, it was reported by
5% for both PS, as well as rACS participants. Difficulties in
concentrating were reported by 10% of the participants after PS,
but not after rACS. There were no cases of acute mood changes,
nausea and visual perceptual changes or lasting adverse events
3 months after stimulation.
Pain
Forty-percent of the subjects reported pain (Figure 2A) during
rACS (mean intensity 2.5, SD 1.73) and 20% during PS (2.75, SD
0.83). While none of the participants reported pain after rACS,
this was the case for 10% after PS (1.5, SD 0.5).
rACS vs. Photic Stimulation
In the statistical analyses, rACS and PS showed no significant
effect of stimulation type (rACS versus PS) on pain intensity as
assessed by Wilcoxon Signed Ranks Tests (Figure 2A), fatigue,
headache and difficulties in concentrating as assessed by Fisher’s
Exact Tests (Figure 2B) during as well as after stimulation. PS and
rACS significantly differed regarding skin sensations of tingling,
itching and burning (P < 0.05, Fisher’s Exact Tests), which all
occurred exclusively in rACS. For a more detailed view, see
Tables 5, 6. The full dataset behind this comparison is available
as Supplementary Material.
DISCUSSION
To address the safety profile of rACS, we assessed theoretical
safety limits as well as finite-element modeling data and
compared the reported adverse events for rACS and simple PS.
The primary findings are that rACS is safe based on the
following observations: (1) stimulation parameters (current and
charge densities at the electrode) are within theoretical safety
limits, (2) finite element modeling data shows the same for EF
estimates and current densities at eye, retina and cortex, and
(3) adverse events are comparable to PS in direct experimental
comparison (see Tables 3, 4) and rate as well as severity of adverse
events did not exceed that of other established brain stimulation
methods (see Table 2).
Stimulation Parameters
To be efficacious and safe, a stimulation system must stimulate
neural tissue without damaging tissue or electrode. Tissue
damage is caused when excitable tissue is overstimulated
and electrode damage ensues as metal oxidation occurs
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FIGURE 2 | Adverse events. A comparison of adverse events between rACS (green) and PS (blue). None of the depicted differences were significant in
Bonferroni-corrected multiple comparisons. (A) Depicted is the mean rating (NRS-11) of overall pain and discomfort in affected subjects during and after stimulation.
Error bars represent the standard deviation. (B) Comparison of shared adverse events (fatigue and headache) in percentage of subjects.
(Peterchev et al., 2012). Current density and charge density have
been proposed as predictors for such damage (Bikson et al., 2016).
Current Density
Current density is the proposed optimal safety parameter for a
constant current stimulation (Nitsche et al., 2003) and can be
TABLE 5 | Results of the Wilcoxon-signed ranks tests.
Asymp. Sig.
Source Z (2-tailed)
Stimtype (rACS vs. PS) Pain (overall) During –0.987a 0.323
After –1.342b 0.180
The results of the statistical analysis on overall pain during and after stimulation.
aBased on positive ranks. bBased on negative ranks.
derived from the effective amplitude and compared to safety
limits (Agnew and McCreery, 1987) as well as other similar
stimulation paradigms (Gekeler et al., 2006; Ma et al., 2014).
We find that rACS current densities are within reported safety
limits for tissue damage (Yuen et al., 1981; Lindenblatt and Silny,
2002; Liebetanz et al., 2009; Gellner et al., 2016).
Charge Density and Charge per Phase
While current density is a well-established safety parameter,
it is best suited for assessing the safety of constant current
stimulation. ACS injects less charge than constant current
stimulation of the same amplitude (Liebetanz et al., 2009;
Schmidt et al., 2013a), dependent on stimulation frequency and
duty cycle (Chaieb et al., 2014). The safety limits of charge
balanced ACS, such as rACS, are therefore more precisely
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TABLE 6 | Results of the Fisher’s exact tests.
Exact Sig.
Source (2-tailed)
Stimtype (rACS vs. PS) Fatigue During 0.480
After 0.480
Difficulties in Concentrating During –
After 0.487
Headache During 0.231
After 1.000
Itching During 0.020∗
After 0.047∗
Burning During 0.020∗
After –
Tingling During 0.000∗
After –
The results of the statistical analysis on the nominally scaled adverse events
presented in Table 4. The asterisk (∗) marks significant results.
determined by charge density and charge per phase (Nitsche et al.,
2003; Merrill et al., 2005).
We find that rACS charge densities are also within reported
safety limits for tissue damage (Yuen et al., 1981; Lindenblatt
and Silny, 2002; Liebetanz et al., 2009; Gellner et al., 2016;
Jackson et al., 2017).
Comparison to Other Stimulation Types
While stimulating at higher current and charge densities
than most forms of tES, rACS stimulation parameters proved
comparable to dose parameters reported for TCES using up to
10 mA per pulse to establish safety guidelines (Gekeler et al.,
2011), well below early montage parameters for both stronger and
longer stimulation used in early studies addressing Electrosleep
therapy (Robinovitch, 1914; Knutson, 1967; Peterchev et al.,
2012), and well below current densities reported for stimulation
via implanted self-sizing spiral cuff electrodes in blind patients
over the course of several years (Delbeke, 2011) (see Table 2).
Despite arguable differences between different stimulation
techniques, there are remarkable similarities, e.g., comparably
distant periorbital montage of electrodes, as well as modeling
results for the serial resistance of the skin and eyelid (Delbeke
et al., 2000; Merrill et al., 2005; Gekeler et al., 2006) to motivate
this comparison.
This leads to the conclusion that the employed charge
injection was safe with regards to possible tissue as well
as electrode damage. In the future, studies addressing the
calculation of rheobase and chronaxie and stimulation with
variable pulse parameters might help to further reduce charge
injection to the minimum necessary to efficaciously achieve a
neuronal response (Irnich, 1980, 2010; Delbeke et al., 2001).
Finite Element Modeling
Electric Field Distribution
Expectedly, the EF distribution shows a clear focus on retina
and optic nerve, while the cortical electric current flow is much
weaker. Due to the electrode montage being superior–inferior,
we see stronger EFs in the temporal regions and at the return
electrode. While there is increased flow through the subcortical
structures, brain stem and cerebellum, there appears to be no
strong current flow to occipital areas, with a maximum current
density of 0.033 A/m2 and a maximum EF of 0.1208 V/m (Table 3
and Figure 1).
This confirms the retinofugal pathway as the primary target
of rACS. Still, stimulation intensity should be closely monitored,
as strong over-threshold stimulation might lead to unwanted
effects on subcortical structures.
Current Densities and EF Estimates
Evidence from relevant animal models indicates that brain
injury by tDCS occurs at predicted brain current densities
(14.9 A/m2) (Liebetanz et al., 2009; Gellner et al., 2016;
Jackson et al., 2017). Considering the well-established threshold
proposed by Liebetanz et al. (2009), rACS maximum current
densities rank two orders of magnitude (OOM) below
lesion threshold for retina and optic nerve and three OOM
below for the cortex.
Additionally, all of the EF estimates are at least one OOM
below the safety threshold of 42 V/m (Liebetanz et al., 2009;
Gellner et al., 2016; Jackson et al., 2017). It should be noted
that, as mentioned above, ACS injects less charge than constant
current stimulation of the same amplitude (Liebetanz et al.,
2009; Schmidt et al., 2013a), and we calculated the current
densities from peak-to-peak amplitude instead of effective
amplitude. The risk of damage will consequently rather be
over-than underestimated. We therefore conclude the rACS
employed in this study should be safe from a modeling
standpoint as well.
Adverse Events
No fatal or serious adverse events (Wester et al., 2008) were
observed for rACS. The most notable adverse events in the
present study were tingling, burning, itching and fatigue. The
hazard rate for these adverse events is to be considered “very
common” (>1/10 cases). This is comparable to results from
other forms of tES (Brunoni et al., 2011), suggesting for tDCS
that the type of adverse event is mild and their frequency of
occurrence is “common.” Direct experimental evidence shows
significantly more cutaneous adverse events, but significantly less
concentration deficits after stimulation for rACS as compared
to PS (Table 5).
As the modeling results showed high maximum current
densities and EF estimates at skin level, the presence of
cutaneous adverse events during and after rACS comes as
no surprise. Comparing rACS and PS regarding the summary
category of pain, we have to note the complete lack of
cutaneous sensations in PS and that multiple aversive sensations
may be clustered and perceived in sum total as painful
(Tuckett, 1982).
Skin Rashes and Damage
None of the subjects reported skin rashes or damage. Whereas
the applied charge density is clearly strong enough to stimulate
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C-nociceptors, it is too low and the duration is too short
to induce skin damage (Dzhokic et al., 2008). For direct
current stimulation, it has been shown that 1 mA via two
7 × 5 cm rubber electrodes in over 2000 stimulation sessions
(Loo et al., 2011) can be applied for 20 min with no
skin damage. Again, ACS is less likely than direct current
stimulation to induce tissue or electrode damage. Although
rACS is unlikely to induce skin damage, this study adhered
to previous suggestions for avoiding cutaneous adverse events
(Loo et al., 2011).
Tingling, Itching and Burning
Electrical stimulation of skin nociceptors is known to produce
itching, burning and tingling sensations in the animal model, as
well as in human subjects (Jarvis and Voita, 1971; Tuckett, 1982;
Kellogg et al., 1989; Ledger, 1992). While even persisting shortly
after stimulation due to central processes, these sensations are
not necessarily indicative of local damage induced by stimulation
(Tuckett, 1982).
Pain
One third of the subjects reported pain with a median
strength of 2.5 NRS. The sensation of pain during and after
electric stimulation is understood to be a combination of
several factors, with the terminal branches of C-nociceptors of
the stimulated skin acting as the primary central conductor
(Magerl et al., 1987; Garnsworthy et al., 1988; Hakkinen
et al., 1995). This matches subject descriptions of deep and
spread pain associated with itch and burning sensations in
this study (six cases) as well as anecdotal reports of painful
perceptions that could not be attenuated by topical anesthetic
and the lack of radiating pain sensations reported elsewhere
(Hakkinen et al., 1995). Due to the common occurrence of
cutaneous sensations, topical anesthesia might be preferential
especially for placebo control or rACS versus PS studies.
This study did not use topical anesthesia, as it might mask
development of skin damage.
While the feeling of pain and discomfort should be monitored
closely in future studies, it should be noted that we found no
significant difference between rACS and well-established and
tolerable PS regarding overall discomfort/pain (Table 5).
This pain during and after PS is most likely a form
of “discomfort glare” associated with visual discomfort,
annoyance, irritability or distraction without affecting the
ability to see, but leading to symptoms of visual fatigue
(Ticleanu and Littlefair, 2015).
Phosphenes
As we stimulated our subjects at 120% phosphene threshold, all
subjects experienced phosphenes. These phosphenes induced by
rACS were typically described as flickering at the edges of the field
of view and not experienced as painful.
Historically, phosphenes induced by alternating current have
been seen as a purely retinal phenomenon (Rohracher, 1935)
resulting from the high susceptibility of the retina to electricity
(Ziemssen, 1864). For rACS and other forms of tES the
amount of confounding retinal or cortical stimulation following
low-voltage stimulation is unknown or a matter of controversy
(Paulus, 2010).
Yet, due to the respective montages there should be a
magnitude of difference between methods (Peterchev et al., 2012)
with TCES inducing the most, rACS with periorbital-occipital
montages intermediate, and tES the least retinal stimulation
(Delbeke et al., 2001; Thil et al., 2007; Paulus, 2010).
A previous tACS modeling effort indicated why transcranial
stimulation may induce retinal phosphenes (Laakso and Hirata,
2013) by virtue of current density induced in the eyes exceeding
phosphene thresholds. As different electrode montages result in
different current flow patterns, whether a particular montage
would result in retinal phosphenes would naturally depend
on the montage being studied. Specifically they show that
the threshold for retinal phosphenes for commonly used
tACS montages is exceeded with stimulation current of 500–
1000 µA (depending on the montage considered). Another
prior tACS/tDCS modeling effort demonstrated that bilateral
montages result in not only more focused current flow but
higher current intensities than midline montages (Neuling
et al., 2012). While no detailed analysis is performed on
the eye regions, the authors state that the closer one of the
stimulation electrodes is to the eye regions, the easier it is to
perceive phosphenes.
Where exactly rACS phosphenes are generated remains
subject to further investigation. While we find the highest EF
estimates in the optic nerve, other authors (Brindley, 1955; Ma
et al., 2014) suggested bipolar cells, or the parts of rod and
cone cells lying inside the external limiting membrane as the
main site of stimulation. In line with the flickering at the edges
of the field of view as reported by our subjects for rACS at
120% phosphene threshold, it can be argued that inner retinal
neurons are the most probable site at which an electrical stimulus
exerts its primary effect, with predominant activation of the
peripheral retina (Ma et al., 2014). This adds further support
to previous findings suggesting that the primary location of
the majority of retinal damage (the retinal pigment epithelium,
RPE) induced by photochemical noxae is bypassed by electrical
stimulation (Grützner et al., 1958). Besides fatigue and cutaneous
effects, the participants described more phosphene or light
related adverse events in association with well-known and safe PS
applied at 120% light threshold than with rACS applied at 120%
phosphene threshold.
Fatigue
Fatigue, reported by one third of the subjects after rACS, has been
suggested in previous research to be an unspecific effect of tES.
Similar to rACS, the early approaches to tES involved two “active”
electrodes placed directly over the eyes, presumably to facilitate
active current delivery through the optic foramina. These
montages were first used in Electrosleep research initiated in
Robinovitch (1914), with extensive research following (Obrosow,
1959; Sergeev, 1963; Brown, 1975). The consensus after about
60 years was that Electrosleep induces unspecific sleepiness and
fatigue related to stimulation (Guleyupoglu et al., 2013).
The findings in this study, that rACS produces more fatigue
than PS, support the notion of an indirect and unspecific central
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(adverse) effect specific to electrical stimulation. This notion is
in line with previous findings showing that action potentials
induced by electrical stimulation of the retina can propagate
directly to the visual cortex (Grützner et al., 1958), produce
different evoked potentials (Potts et al., 1968) and modulate
central rhythms (Schmidt et al., 2013a) as well as large scale
networks of the brain (Bola et al., 2014).
CNS Damage and Seizure Risk
Beyond fatigue, the possibility of direct structural damage to
central nervous structures by rACS seems low considering the
distance between charge injection and brain tissue as well as
stimulation strength. Yet, for rhythmic PS the danger of inducing
an epileptic seizure is well established. Although not found
in this study, for electrical stimulation the danger must also
be assumed to be high due to neurophysiological similarities
with intermittent photic stimulation (IPS) (Brindley, 1955) and
proven effects on central processes and neural synchrony (Parra
et al., 2003). Additionally, although no reports of seizures after
comparable electrical stimulation sessions exist (Brunoni et al.,
2012), we will continue to employ photosensitivity and epilepsy
as exclusion criteria for future rACS studies.
CONCLUSION AND OUTLOOK
Having theoretically and experimentally characterized the
relative safety profile of rACS, we believe future studies can
further investigate retinal mechanisms of action for ACS effects,
especially in comparison with tACS. Additionally, rACS allows
for studies addressing the interaction of different signal types
entering the visual system through two separate input channels
(left and right eye) and converging at the level of the primary
visual cortex. This provides an promising tool for studies
aiming to address a common framework of action for NiBS
with more than one input-signal, e.g., noise and oscillation
(Schmidt et al., 2013b).
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